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The entorhinal cortex (EC) is regarded as the gateway
to the hippocampus and thus is essential for learning
and memory. Whereas the EC expresses a high
density of GABAB receptors, the functions of these
receptors in this region remain unexplored. Here,
we examined the effects of GABAB receptor activa-
tion on neuronal excitability in the EC and spatial
learning. Application of baclofen, a specific GABAB
receptor agonist, inhibited significantly neuronal ex-
citability in the EC. GABAB receptor-mediated inhibi-
tion in the EC was mediated via activating TREK-2,
a type of two-pore domain K+ channels, and required
the functions of inhibitory G proteins and protein
kinase A pathway. Depression of neuronal excit-
ability in the EC underlies GABAB receptor-mediated
inhibition of spatial learning as assessed by Morris
water maze. Our study indicates that GABAB recep-
tors exert a tight control over spatial learning by
modulating neuronal excitability in the EC.
INTRODUCTION
g-Aminobutyric acid (GABA) is a major inhibitory neurotrans-
mitter in the central nervous system, where it acts at ionotropic
(GABAA and GABAC) and metabotropic (GABAB) receptors.
Whereas the functions of GABAA and GABAC receptors are to
mediate fast inhibitory synaptic transmission, stimulation of
GABAB receptors (GABABRs) modulates synaptic function via
G proteins and intracellular signals (Couve et al., 2000).
GABABRs consist of heterodimers of GABAB1 and GABAB2
subunits that are coupled to inhibitory G proteins (Gai and
Gao), which inhibit adenylyl cyclase (AC), resulting in a reduction
in cyclic AMP (cAMP) generation and an inhibition of protein
kinase A (PKA) (Couve et al., 2000). GABABRs play important
modulatory roles in cognition, nociception, neuroprotection,
depression, addiction, and epilepsy (Couve et al., 2000).
Anatomically, the entorhinal cortex (EC) mediates the majority
of the connections between the hippocampus and other cortical230 Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc.areas (Witter et al., 1989, 2000a). Sensory inputs converge onto
the superficial layers (layers II–III) of the EC (Burwell, 2000), which
give rise to dense projections to the hippocampus; the axons of
the stellate neurons in layer II of the EC form the perforant path
that innervates the dentate gyrus andCA3 (Steward and Scoville,
1976), whereas those of the pyramidal neurons in layer III form
the temporoammonic pathway that synapses onto the distal
dendrites of pyramidal neurons in CA1 and the subiculum
(Steward and Scoville, 1976; Witter et al., 2000a, 2000b). More-
over, neurons in the deep layers of the EC (layers V–VI) relay
a large portion of hippocampal output projections back to the
superficial layers of the EC (Dolorfo and Amaral, 1998a, 1998b;
Kohler, 1986; van Haeften et al., 2003) and to other cortical areas
(Witter et al., 1989). The EC is part of a network that aids in the
consolidation and recall of memories (Haist et al., 2001; Squire
et al., 2004; Steffenach et al., 2005). Neuronal pathology and
atrophy of the EC are potential contributors to Alzheimer’s
disease (Hyman et al., 1984; Kotzbauer et al., 2001) and
schizophrenia (Falkai et al., 1988; Prasad et al., 2004). Further-
more, the EC participates in the induction and maintenance of
temporal lobe epilepsy (Avoli et al., 2002; Spencer and Spencer,
1994).
GABABRs are densely expressed in the principal cells, espe-
cially the stellate neurons, of the EC (Mizukami et al., 2002).
However, the functions of GABABRs in this brain region remain
unexplored. Because GABABRs and the EC are closely associ-
ated with cognitive function in the brain, we tested the hypoth-
esis that GABABRs expressed in the EC modulate neuronal
excitability and participate in learning and memory. Our results
demonstrate that GABABR activation drastically inhibited
neuronal excitability in the superficial layers of the EC via acti-
vation of TREK-2, a type of two-pore domain K+ (K2P) channels.
We also found that the functions of pertussis toxin (PTX)-sensi-
tive G proteins, PKA and A-kinase anchoring proteins (AKAPs)
are necessary for GABABR-mediated inhibition in the EC.
Microinjection of the GABABR agonist, baclofen, and Rp-
cAMPS, a specific PKA inhibitor, into the EC of rats prevented
spatial learning whereas downregulation of TREK-2 channels
using siRNA significantly reduced the effect of baclofen on
spatial learning suggesting that GABABR-mediated inhibition
of neuronal excitability contributes significantly to spatial
learning.
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GABAB Activates TREK-2 in Entorhinal CortexFigure 1. Baclofen Reduces the Excitability of Stellate Neurons by
Generating Membrane Hyperpolarization
(A) Voltage responses (upper panel) generated by current injection from
+0.1 nA to1 nA at an interval of0.1 nA (lower panel) recorded from a stellate
neuron in layer II. Note the depolarizing voltage sags in response to hyperpo-
larizing current pulses.
(B) AP firing recorded prior to, during, and after application of baclofen from the
stellate neuron in A.
(C) Pooled time course of AP firing frequency before, during, and after applica-
tion of baclofen.
(D) Baclofen-mediated inhibition of AP firing was blocked in the presence of
the GABABR blocker, CGP 55845.
(E) Baclofen generated membrane hyperpolarization and reduced input resis-
tance. A negative current (50 pA for 500 ms) was injected every 5 s to assess
the changes of input resistance. Insets are the voltage traces taken before (a)
and during (b) the application of baclofen. Note that baclofen induced
membrane hyperpolarization and reduced the voltage responses induced by
the negative current injections, suggesting a reduction in input resistance.
To exclude the influence of baclofen-induced membrane hyperpolarizationRESULTS
GABABR Activation Inhibits Action Potential
Firing in the EC
GABABRs are densely expressed in the EC, especially in the stel-
late neurons of the superficial layers (Mizukami et al., 2002).
Accordingly, we examined first the effects of GABABR activation
on the excitability of stellate neurons. The extracellular solution
contained DNQX (10 mM), dl-APV (50 mM), and bicuculline
(10 mM) to block synaptic transmission. Stellate neurons were
differentiated by their location, morphology and electrophysi-
ology properties (Deng et al., 2007). Figure 1A shows the
current-voltage responses from a stellate neuron in layer II of
the EC. This neuron showed profound depolarizing voltage
sags in response to hyperpolarizing current pulses (Deng et al.,
2007). Application of baclofen (100 mM), a specific GABABR
agonist, completely blocked action potential (AP) firing within
5–6 min of application (n = 6, p < 0.001, Figures 1B and 1C).
AP firing frequency recovered partially after wash for 25 min
(Figure 1C). The effect of baclofen was mediated by GABABRs
because application of CGP 55845 (2 mM), a specific GABABR
inhibitor, completely blocked baclofen-induced inhibition of AP
firing (101% ± 2% of control, n = 7, p = 0.76, Figure 1D). These
results indicate that GABABR activation drastically inhibits
neuronal excitability in the EC.
GABABR Activation Generates Hyperpolarization
Inhibition of AP firing could be attributable to GABABR-induced
membrane hyperpolarization. We therefore recorded the resting
membrane potentials (RMPs) in current-clamp in the presence of
TTX (0.5 mM) to block potential indirect effects from synaptic
transmission. A negative current (50 pA for 500 ms) was
injected every 5 s to assess the changes of input resistance.
Application of baclofen (100 mM) generated membrane hyperpo-
larization (control:56.5 ± 1.3mV, baclofen:61.8 ± 1.4mV, n =
7, p < 0.001, Figures 1E and 1F) and reduced the input resistance
(control: 98.3 ± 13.1MU, baclfen: 75.0 ± 7.7MU, n = 7, p < 0.006,
Figure 1E), suggesting that GABABR activation increases
membrane conductance. We then recorded the holding currents
(HCs) in voltage-clamp at60mV, a potential close to the RMPs.
Under these conditions, application of baclofen (100 mM) gener-
ated an outward HC. The maximal effect usually occurred
on input resistance, a constant positive current (+70 pA indicated by the hori-
zontal bar) was injected briefly to elevate the membrane potential to the initial
level. Under these conditions, the voltage responses induced by the negative
current injections (50 pA) were still smaller compared with control, suggest-
ing that baclofen-induced reduction in input resistance is not secondary to its
effect on membrane hyperpolarization.
(F) Summarized data for baclofen-induced changes in RMPs. Filled circles
denote the averaged values.
(G) Baclofen induced an outward HC. HCs were averaged per min and zeroed
to the level just prior to the application of baclofen. Inset shows the averaged
HCs recorded at the time points denoted in the figure. A5mV hyperpolarizing
voltage step was used at the end of each trace to monitor potential changes of
series resistance during recordings.
(H) Concentration-response curve for baclofen-induced changes in HCs.
Numbers in the parenthesis were number of cells recorded. Data represent
means ± SEM.Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc. 231
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GABAB Activates TREK-2 in Entorhinal Cortex4–6 min after the beginning of baclofen application (90.9 ±
17.9 pA, n = 11, p < 0.001, Figure 1G) and was used for statistical
analysis thereafter. The EC50 value for baclofen was calculated
to be 1.03 mM (Figure 1H).
Baclofen-Induced Hyperpolarization Is
G Protein-Dependent and Requires
the Functions of PKA and AKAPs
GABABRs are G protein coupled (Couve et al., 2000). We next
examined the requirement of G proteins in baclofen-induced
hyperpolarization. We replaced the intracellular GTP with GDP-
b-S (4mM),aGprotein inactivatorand recordedbaclofen-induced
changes in HCs at60mV. In the presence of GDP-b-S, baclofen
did not significantly change theHCs (4.3 ± 2.7 pA, n = 12, p = 0.13,
Figure 2A), suggesting that baclofen-induced hyperpolarization is
mediated by G proteins. We then identified the type of G proteins
involved in baclofen-induced hyperpolarization. GABABRs acti-
vate the inhibitory G proteins (Gai and Gao, Couve et al., 2000),
and theseGproteins are sensitive toPTX.We therefore pretreated
slices with PTX (500 ng/ml) in the extracellular solution continu-
ously oxygenatedwith 95%O2 and 5%CO2 for8 hr. Bath appli-
cation of baclofen (100 mM) failed to significantly increase the
outward HCs in slices pretreated with PTX (2.5 ± 3.2 pA, n = 8,
p = 0.47, Figure 2B) whereas baclofen still increased the outward
HCs in slices treated in the same fashion without PTX (98.8 ±
10.6pA, n=6,p<0.001, Figure2B), suggesting thatPTX-sensitive
G proteins (Gai or Gao) are involved in baclofen-induced hyperpo-
larization.
GABABR activation inhibits AC and reduces the levels of cAMP
thereby inhibiting PKA (Couve et al., 2000). We next determined
the roles of this pathway in GABABR-induced hyperpolarization.
Intracellular dialysis of MDL-12,330A (2 mM), an AC inhibitor, via
the recording pipettes for 30 min immediately after the forma-
tion of whole-cell configuration induced an outward HC (192.7 ±
19.6 pA, n = 7, p < 0.001, Figure 2C) and extensively reduced
baclofen-induced increases in outward HCs (15.7 ± 6.4 pA, n =
7, p = 0.005 versus baclofen alone, Figure 2C) suggesting that
activity of AC is required. Likewise, intracellular application of
Rp-cAMPS (1 mM), a specific PKA inhibitor, in the recording
pipettes for 20 min induced an outward HC (215.1 ± 22.9 pA,
n = 7, p < 0.001, Figure 2D) and completely blocked baclofen-
induced increases in outward HCs (3.8 ± 7.2 pA, n = 7, p =
0.62, Figure 2D). Furthermore, intracellular application of
KT5720 (1 mM), another PKA inhibitor, also induced an outward
HC (152.3 ± 20.5 pA, n = 6, p < 0.001, data not shown) and signif-
icantly reduced baclofen-induced outward HCs (13.5 ± 6.1 pA,
n = 6, p = 0.006 versus baclofen alone, Figure 2E). These
results together demonstrate that PKA pathway is necessary
for baclofen-induced increases in outward HCs.
We further corroborated the roles of PKA pathway by applying
forskolin (an AC activator) and 3-isobutyl-1-methylxanthine
(IBMX, a phosphodiesterase inhibitor) to elevate intracellular
cAMP level. Coapplication of forskolin (10 mM) and IBMX (1 mM)
generated an inwardHCper se (72.4 ± 14.4 pA, n = 6, p < 0.001,
Figure 2E) and significantly reduced baclofen-induced outward
HCs (35.2 ± 8.0 pA, n = 6, p = 0.011 versus baclofen alone,
Figure 2E). Moreover, application of the specific PKA activator,
Sp-cAMPS (100 mM), induced an inward HC by itself (30.5 ±232 Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc.7.2 pA, n = 6, p < 0.001, Figure 2E) and significantly diminished
the effect of baclofen (4.1 ± 3.4 pA, n = 6, p < 0.001 versus baclo-
fen alone, Figure 2E). Finally, bath application of okadaic acid
(OA, 0.1 mM), a protein phosphatase inhibitor that inhibits the
dephosphorylation process, induced an inward HC (31.9 ±
13.2 pA, n = 6, p < 0.001) and significantly reduced baclofen-
induced outward HC (31.3 ± 6.0 pA, n = 6, p = 0.006 versus
Figure 2. GABABR-Mediated Inhibition Requires the Functions of
Inhibitory G Proteins, AC, PKA, and AKAPs
(A) Intracellular application of GDP-b-S via the recording pipettes blocked
baclofen-induced increases in outward HCs.
(B) Treatment of slices with PTX abolished the effects of baclofen on HCs,
whereas treatment of the slices in the same fashion without PTX failed to alter
the effect of baclofen.
(C) Intracellular dialysis of MDL-12,330A induced an outward HC and signifi-
cantly inhibited baclofen-induced increases in outward HCs. HCs at 60 mV
were recorded immediately after the formation of whole-cell configuration,
and the actual HCs were used to plot the figure.
(D) Application of Rp-cAMPS in the recording pipettes induced an outward HC
and blocked baclofen-induced increases in outward HCs. The actual HCs
were used to plot the figure.
(E) Baclofen-induced increases in outward HCs were significantly reduced by
coapplication of KT5720, forskolin plus IBMX, Sp-cAMPS, or okadaic acid
(OA) (*p < 0.05, **p < 0.01 versus baclofen alone; ++p < 0.01 versus
baseline = 0).
(F) Inclusion of St-Ht31, the AKAP inhibitory peptide, in the recording pipettes
significantly inhibited baclofen-induced increases in outward HCs, whereas
application of St-Ht31P, the control peptide, had no effects. Data represent
means ± SEM.
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that PKA-mediated phosphorylation exerts a tonic control over
neuronal excitability in the stellate neurons of the EC.
AKAPs play a crucial role in the functional expression of PKA
by tethering PKA to other signaling substrates (Beene and Scott,
2007). Whereas AKAPs are a diverse family of more than 50 scaf-
folding proteins, they share a structurally conserved PKA-
binding domain (Hundsrucker and Klussmann, 2008). Disruption
of AKAPs by application of the PKA-anchoring inhibitory peptide
has been shown to prevent a myriad of functions ascribed to
PKA (Hundsrucker and Klussmann, 2008). Intracellular perfusion
of the AKAP inhibitory peptide (St-Ht31, 20 mM) dramatically
inhibited baclofen-induced increases in outward HCs (16.5 ±
2.9 pA, n = 6, p = 0.004, Figure 2F) compared with those when
the control peptide (St-Ht31P, 20 mM) was applied via the
recording pipettes (85.1 ± 16.9 pA, n = 7, Figure 2F), demon-
strating that the function of AKAPs is required for baclofen-
induced hyperpolarization. Together, these results indicate that
GABABRs exert powerful inhibition on neuronal excitability via
PTX-sensitiveG protein-mediated inhibition of AC-PKApathway.
GABABR-Induced Hyperpolarization Is Mediated
by Activation of K2P Channels
We next tested the hypothesis that GABABR activation opens
background K+ channels to generate membrane hyperpolariza-
tion in the EC. We first replaced the intracellular K+ with the
same concentration of Cs+ on the basis that if K+ channels are
involved, replacement of intracellular K+ with Cs+ should block
baclofen-induced increases in outward HCs because K+ chan-
nels are not permeable to intracellular Cs+.When the intracellular
K+ was replaced by Cs+, instead of inducing an outward HC,
application of baclofen (100 mM) induced a small inward HC
(16.3 ± 3.5 pA, n = 5, p = 0.01, Figure 3A), suggesting that K+
channels are required for baclofen-induced hyperpolarization.
One plausible explanation for baclofen-induced inward currents
under this condition was the reverse K+ flowing via K+ channels
from extracellular side when intracellular K+ was replaced by
Cs+. We then measured the reversal potential of baclofen-
induced currents using a ramp protocol prior to and during the
application of baclofen because if K+ channels are involved,
the currents generated by GABABR activation should have a
reversal potential close to the K+ reversal potential. Application
of baclofen (100 mM) in the presence of 3.5 mM K+ induced a net
current that had a reversal potential of90.1 ± 4.7mV (n = 9, Fig-
ure 3B), close to the theoretical K+ reversal potential calculated
by the Nernst equation (92.2 mV) suggesting that baclofen
produces membrane hyperpolarization by activating a back-
ground K+ conductance. The net current generated by baclofen
had an outward rectification property (Figure 3B, inset). Further
evidence to support the involvement of K+ channels was that
elevating extracellular K+ concentration to 10 mM significantly
reduced baclofen-induced outward HCs (21.9 ± 7.9 pA, n = 6,
p = 0.02 versus baclofen alone, Figure 3C). Together, these
data indicate that GABABR activation induces hyperpolarization
by activating a background K+ conductance.
We then identified the properties of the involved K+ channels.
Baclofen-induced increases in outward HCs were not signifi-
cantly altered (versus baclofen alone) in the extracellular solutioncontaining tetraethylammonium (TEA, 10 mM, n = 8, p = 0.32,
Figure 3C), 4-aminopyridine (4-AP, 2 mM, n = 6, p = 0.96,
Figure 3C), Cs+ (3 mM, n = 5, p = 0.57, Figure 3C), or tertiapin
(50 nM, n = 7, p = 0.82, Figure 3C) suggesting that baclofen-acti-
vated K+ channels are insensitive to the classic K+ channel
blockers.
K2P channels are involved in controlling RMPs and they are
insensitive to the classic K+ channel blockers. We next examined
the rolesofK2Pchannels inbaclofen-inducedmembranehyperpo-
larization. K2P channels can be divided into six subfamilies: TWIK,
THIK, TREK, TASK, TALK, and TRESK (Bayliss et al., 2003; Les-
age, 2003), some of which are sensitive to Ba2+. We therefore
tested the roleofBa2+ inbaclofen-inducedmembranehyperpolar-
ization. Inclusion of Ba2+ (2mM) in the extracellular solution per se
generated an inward HC (79.6 ± 22.9 pA, n = 7, p = 0.01,
Figure 3D) and subsequent application of baclofen (100 mM)
induced a significantly smaller outward HC (8.6 ± 1.9 pA, n = 7,
p = 0.002 versus baclofen alone, Figure 3D). Together, our results
Figure 3. GABABR-Mediated Increases in Outward HCs Are Me-
diated by Activation of K2P Channels
(A) Bath application of baclofen induced a small inward current when
Cs+-gluconate-containing intracellular solution was used in contrast to baclo-
fen-induced outward currents when the intracellular solution contained
K+-gluconate.
(B) Voltage-current relationship induced by a ramp protocol from 140 mV to
0 mV at a speed of 0.1 mV/ms prior to and during the application of baclofen.
Subtraction of the current prior to the application of baclofen generated a net
current of outward rectification (inset). The traces were averages from nine
cells. Note that the reversal potential was 90.1 mV, close to the calculated
K+ reversal potential (92.2 mV).
(C) Baclofen-induced increases in outward HCs were insensitive to extracel-
lular application of TEA, 4-AP, Cs+, and tertiapin, but reduced when the extra-
cellular K+ concentration was increased to 10 mM (*p = 0.02).
(D) Inclusion of Ba2+ in the extracellular solution induced an inward HC but
significantly reduced baclofen-induced increases in outward HCs. Data re-
present means ± SEM.Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc. 233
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larization by activating Ba2+-sensitive K2P channels.
TREK-2 Channels Are Involved in Baclofen-Induced
Hyperpolarization
Among the K2P channels, TASK-1 (Han et al., 2002), TASK-3
(Han et al., 2002; Kim et al., 2000), TREK-1 (Fink et al., 1996),
Figure 4. TREK-2 Channels Are Involved in
GABABR-Mediated Hyperpolarization
(A) Immunocytochemical staining of K2P channels
in the EC (layer I–VI). Upper panels: low magnifica-
tion, low panels: high magnification of the regions
marked in the upper panels. The catalog numbers
of the ABs were labeled on the top.
(B) (a–d) Intracellular infusion of ABs to TASK-1
(a), TASK-3 (b), TWIK-1 (c), and TREK-1 (d) at
40 mg/ml failed to significantly change baclofen-
induced increases in outward HCs. (e) Intracellular
dialysis of two TREK-2 ABs (40 mg/ml) drastically
reduced baclofen-induced increases in outward
HCs. (f) Intracellular application of the third TREK-2
AB (APC-055,AlomoneLabs, 40mg/ml) significantly
reduced the effect of baclofen whereas application
of the TREK-2 AB preabsorbed with the corre-
sponding blocking peptide via the recording
pipettes significantly reduced the inhibitory effect
of TREK-2 AB. Data represent means ± SEM.
TREK-2 (Han et al., 2002), TWIK-1 (Les-
age et al., 1996), and TRESK (Kang
et al., 2004; Sano et al., 2003) are sensi-
tive to Ba2+. TRESK channels are unlikely
to be involved because they are ex-
pressed in the spinal cord and other
organs but not in the brain (Kang et al.,
2004; Sano et al., 2003). We examined
the immunoreactivity of TASK-1, TASK-3,
TWIK-1, TREK-1, and TREK-2 in the EC
using two sets of antibodies (ABs, Santa
Cruz Biotechnology Inc.). Immunoreactiv-
ities for all these K2P channels especially
for TASK-1 and TREK-2 were detected
in the EC (Figure 4A). Similar patterns
of immunoreactivities were detected in
the EC when the second set of K2P ABs
against distinct domains of the channels
were used (Figure S1A) whereas preab-
sorption of the ABs with their corre-
sponding blocking peptides blocked the
detection of the immunoreactivities (Fig-
ure S1B).
We then identified the roles of these
K2P channels in baclofen-induced hyper-
polarization by applying, via the recording
pipettes, specific ABs against each chan-
nel type. The rationale for this experi-
ment was that the epitopes for all these
ABs are against intracellular C- or N-ter-
minal domains of the channels (Goldstein et al., 2001) and intra-
cellular application of these ABs would interfere with the function
of the corresponding K2P channels and block or at least reduce
the effects of baclofen. To ensure a complete intracellular diffu-
sion of the ABs, we waited for 60 min after formation of
whole-cell recordings. Under these conditions, application of
control Ig-G (sc-2028, n = 5, p = 0.42 versus baclofen alone,234 Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc.
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Figure 4Ba), TASK-3 (sc-11322, n = 6, p = 0.97, Figure 4Bb),
TWIK-1 (sc-11483, n = 7, p = 0.71, Figure 4Bc), and TREK-1
(sc-11554, n = 6, p = 0.31, Figure 4Bd) failed to change baclo-
fen-induced increment of outward HCs significantly (versus
control Ig-G) whereas inclusion of the AB to TREK-2 (sc-11560)
dramatically reduced baclofen-induced augmentation of out-
ward HCs (10.9 ± 4.7 pA, n = 6, p < 0.001 versus control IgG,
Figure 4Be). We used the following approaches to confirm the
specificities of the ABs further. First, intracellular application of
the second TREK-2 AB (sc-11559) against distinct epitopes of
TREK-2 channels also significantly reduced baclofen-induced
increases in outward HCs (14.5 ± 4.9 pA, n = 7, p = 0.002 versus
control Ig-G, Figure 4Be). Similar results were obtained when the
third TREK-2 AB (APC-055, Alomone Labs) was included in the
recording pipettes (11.8 ± 2.9 pA, n = 6, p = 0.001 versus control
Ig-G, Figure 4Bf) whereas intracellular application of the TREK-2
AB preabsorbed with the corresponding blocking peptide signif-
icantly reduced the inhibitory effect of the TREK-2AB (86.6 ± 13.9
pA, n = 6, p < 0.001 versus anti-TREK-2 alone, Figure 4Bf), indi-
cating that TREK-2 channels are indeed required. Second, we
repeated theaboveelectrophysiological experiments by intracel-
lular application of the second set of the ABs to TASK-1, TASK-3,
TWIK-1, and TREK-1. Similar results were obtained (Figure S2),
suggesting that these K2P channels are not involved. Third, we
transfected HEK293 cells with GFP and individual K2P channels
and immunostained the transfectedcellswith theK2PABs. Immu-
noreactivity of individual K2P channels was detected only in
HEK293 cells transfected with the corresponding channels and
there were no cross reactions among those ABs (Figure S3A).
Finally, we tested the effectiveness of intracellular application
of the ABs to TASK-1, TASK-3, TREK-1, and TWIK-1 at inhibiting
the functions of these channels in transfected cells. We applied
via the recording pipettes the individual K2P channel ABs to the
HEK293 cells expressing the corresponding K2P channels and
recorded the changes of the HCs at60mV. Intracellular dialysis
of these ABs inhibited the channel function by producing an
inward HC whereas intracellular application of an irrelevant AB
(anti-TREK-2) failed to change the HCs significantly (Figures
S3B–S3E). These data indicate that the ineffectiveness of intra-
cellular application of ABs to TASK-1, TASK-3, TREK-1, and
TWIK-1 to block the effect of baclofen in the stellate neurons of
the EC was unlikely due to the inability of the ABs to inhibit these
channels.
The function of TREK-2 channels is upregulated by intracel-
lular acidification, heat and arachidonic acid (AA) (Huang and
Yu, 2008; Kim, 2005). We next tested the effects of these factors
on GABABR-mediated hyperpolarization in the EC. Intracellular
acidification achieved by substituting 90 mM NaCl with 90 mM
NaHCO3 in the extracellular solution (Fakler et al., 1996;Maingret
et al., 1999) induced an outward HC and significantly reduced
baclofen-induced increases in outward HCs (Figure S4). Eleva-
tion of the temperature in the recording chamber to 33C also
induced an outward HC by itself and significantly diminished
baclofen-induced enhancement of outward HCs (Figure S4).
However, bath application of AA (10 mM) alone induced an
inward HC instead (Figure S4). Because AA interacts with
many ion channels (Meves, 1994) including the cationic channelssuch as H- (Fogle et al., 2007) and TRP (Oike et al., 2006) chan-
nels and these channels are expressed in the EC (Dickson et al.,
2000; von Bohlen Und Halbach et al., 2005), one explanation for
this unexpected result is that AA-induced inward HCs might be
the neutralized effect of AA on TREK-2 and other channels such
as the cationic channels. To test this possibility, we replaced
extracellular NaCl with the same concentration of N-methyl-D-
glucamine (NMDG)-Cl and omitted extracellular Ca2+ tominimize
the contribution of cationic channels to RMPs. Under these
circumstances, application of AA indeed induced an outward
HC per se (Figure S4) and also significantly reduced baclofen-
induced enhancement of outward HCs compared with the effect
of baclofen in this condition without AA (Figure S4). Collectively,
these results further support the involvement of TREK-2 chan-
nels in GABABR-mediated hyperpolarization.
We then cotransfected GABABRs with TREK-2 channels in
HEK293 cells and recorded the HCs at 60 mV from the trans-
fected cells. Application of baclofen (100 mM) generated an
outward HC in cells cotransfected with GABABRs and TREK-2
channels (183 ± 41 pA, n = 7, p = 0.004, Figures 5A and 5B)
whereas application of the same concentration of baclofen failed
to significantly change the HCs in HEK293 cells transfected with
either TREK-2 channels (0.6 ± 1.9 pA, n = 6, p = 0.78, Figures 5A
and 5B) or GABABRs (1.5 ± 1.5 pA, n = 6, p = 0.35, data not
shown). The reversal potential for baclofen-induced current
was 89.2 ± 2.2 mV in cells cotransfected with GABABRs and
TREK-2 (n = 6, Figure 5C), which was close to the calculated K+
reversal potential (96.1 mV) in our recording conditions. Appli-
cation of TREK-2 AB (sc-11560, 40 mg/ml) via the recording
pipettes to the HEK293 cells cotransfected with GABABRs and
TREK-2 channels also generated an inward HC (446.3 ±
84.8 pA, n = 6, p = 0.003, Figure 5D) and significantly reduced ba-
clofen-induced increases in outward HCs (27.9 ± 5.3 pA, n = 6,
p = 0.005 versus baclofen alone in transfected cells, Figure 5D)
whereas intracellular application of TREK-1 AB (sc-11554,
40 mg/ml) failed to change baclofen-induced outward HCs
(181.1 ± 18.4 pA, n = 6, p = 0.97 versus baclofen alone, Figure 5E).
Similar results were obtained by using other two TREK-2 ABs
(Figure5F) furtherdemonstrating the requirementofTREK-2chan-
nels. Finally, dialysis of Rp-cAMPS (1 mM) into the HEK293 cells
expressing GABABRs and TREK-2 channels induced an outward
HC (357.1 ± 74.7 pA, n = 7, p = 0.003, Figure 5F) and significantly
reduced the effect of baclofen (12.6 ± 14.3 pA, n = 7, p = 0.002
versus baclofen alone, Figure 5F) demonstrating the involvement
of PKA. Collectively, these results indicate that GABABR ac-
tivation inhibits PKA resulting in increases in the function of
TREK-2 channels to generate hyperpolarization in the EC. In
agreement with our results, both TREK-1 (Fink et al., 1996; Mur-
bartia´n et al., 2005) and TREK-2 (Bang et al., 2000; Lesage et al.,
2000) channels are inhibited by PKA-mediated phosphorylation.
TREK-2 channels are phosphorylated by PKA on serine 359 of
the C terminus (Bang et al., 2000). Because our preceding results
demonstrate that PKA is required for GABABR-induced hyperpo-
larization, we tested the role of the PKA phosphorylation site on
TREK-2 channels in GABABR-mediated hyperpolarization in
HEK293 cells coexpressing GABABRs and the mutant TREK-2
channels in which serine 359 was mutated to alanine (S359A)
to nullify PKA-mediated phosphorylation of TREK-2 channelsNeuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc. 235
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Mediated Phosphorylation Site on TREK-2 Channels
(A) Left panel: HCs recorded at 60 mV from a HEK293 cell transfected with
TREK-2 alone before (a) and during (b) the application of baclofen (100 mM).
Right panel: HCs recorded at 60 mV from a HEK293 cell cotransfected
with GABABRs and TREK-2 channels before (a) and during (b) the application
of baclofen.
(B) Summarized data from six HEK293 cells transfected with TREK-2 channels
alone and seven HEK293 cells cotransfected with GABABRs and TREK-2
channels.
(C) Baclofen-induced currents had a reversal potential (89.2 ± 2.2 mV, n = 6)
close to the reversal potential of K+ (96.1 mV). Inset, net current induced by
baclofen.
(D) Intracellular application of the first TREK-2 AB (40 mg/ml) to the HEK293
cells coexpressing GABABRs and TREK-2 channels generated an inward HC
per se and significantly reduced baclofen-induced increases in outward
HCs. HCs at 60 mV were recorded immediately after the formation of
whole-cell configuration and the actual HCs were used to plot the figure.
(E) Intracellular application of TREK-1 AB (40 mg/ml) had little effects on HCs
and did not significantly change baclofen-induced increases in outward
HCs. HCs at 60 mV were recorded immediately after the formation of
whole-cell configuration and the actual HCs were used to plot the figure.236 Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc.(Kang et al., 2007a). Alanine substitution of this site did not
prevent the expression and functions of TREK-2 channels in
HEK293 cells (Kang et al., 2007a). However, application of
baclofen (100 mM) failed to change the HCs significantly in
HEK293 cells coexpressing S359A mutant and GABABRs
(5.4 ± 5.0 pA, n = 9, p = 0.32, Figure 5G) and there was little
change in the voltage-current relationship when baclofen was
applied (Figure 5H). Together, these results indicate that serine
359, the PKA phosphorylation site on TREK-2 channels is neces-
sary for GABABR-mediated hyperpolarization.
GABABR Activation in the EC Impairs Spatial Learning
in Morris Water Maze via PKA-Dependent Activation
of TREK-2 Channels
We then tested the roles of GABABR activation in spatial learning
using Morris water maze. Rats receiving intra-EC infusion of
normal saline (0.9% NaCl) (control, 1 ml/rat, n = 7 rats) acquired
spatial learning rapidly as shown by a significant decrease in
latency to find the hidden platform throughout the trials (F(11,66) =
5145.33, p < 0.001, Figure 6A). Intra-EC infusion of baclofen
(5 mg/rat in 1 ml, n = 8 rats) completely prevented the spatial
learning of rats because the escape latencies were not reduced
throughout the trials (F(11,77) = 1.682, p = 0.093, Figures 6A and
6B). The effect of baclofen was mediated via activation of
GABABRs because microinjection of the GABABR antagonist,
CGP55845 (1 mg/rat in 1 ml, n = 8 rats) completely blocked baclo-
fen-induced impairment of spatial learning (F(1,14) = 47.89, p <
0.001 betweenCGP55845 + baclofen group and baclofen group,
Figures 6A and 6B). Because the function of PKA is involved in
GABABR-mediated depression of neuronal excitability in the
EC, we then tested the roles of PKA in spatial learning. Intra-
EC application of Rp-cAMPS (18 mg/rat in 1 ml, n = 8 rats) pre-
vented spatial learning as the latencies were not significantly
reduced throughout the trials (F(11,77) = 0.55, p = 0.862, Figures
6A and 6B), suggesting that endogenous PKA controls spatial
learning (Arnsten et al., 2005). In the probe trials, control rats
and rats treated with CGP55845 or CGP55845 followed by ba-
clofen showed a significant bias for the target quadrant where
the platform had been originally located (p < 0.01 for each group
compared with the chance level 25%). However, rats in other
(F) Intracellular dialysis of the second TREK-2 AB (AB2, sc-11559, 40 mg/ml)
into the HEK293 cells cotransfected with GABABRs and TREK-2 channels
generated an inward holding current (n = 6, ++p < 0.01 versus baseline = 0)
and significantly inhibited baclofen-induced increases in outward holding
currents (n = 6, **p < 0.01 versus baclofen alone). Intracellular perfusion of
the third TREK-2 AB (AB3, APC-055, Alomone labs, 40 mg/ml) induced an
inward holding current (n = 6, ++p < 0.001 versus baseline = 0) and significantly
inhibited the effect of baclofen (n = 6, **p < 0.01 versus baclofen alone). Intra-
cellular application of Rp-cAMPS (1 mM) into the HEK293 cells cotransfected
with GABABRs and TREK-2 channels induced an outward holding current
(n = 7, ++p < 0.01 versus baseline = 0) and significantly reduced the effect of
baclofen (n = 7, **p < 0.01 versus baclofen alone).
(G) Application of baclofen did not change the HCs significantly in HEK293
cells cotransfected with S359A mutant TREK-2 channels and GABABRs. Inset
shows the holding currents before and during the application of baclofen.
(H) Application of baclofen did not induce significant changes in the voltage-
current relationship recorded from HEK293 cells coexpressing GABABRs
and S359A mutant TREK-2 channels. Data represent means ± SEM.
Neuron
GABAB Activates TREK-2 in Entorhinal Cortexgroups failed to show preference for the target quadrant
(Figure 6C). The microinjection sites were confirmed at the end
of each experiment (Figure 6D). Together with the electrophysi-
ological data, these results suggest that GABABR activation
depresses spatial learning via inhibition of PKA.
The water maze performance is subject to the influences of
other nonspatial learning factors, such as the sensory, motiva-
tional, emotional, or motor functions of the tested subjects. We
took the followingmeasures to ensure that the effects of baclofen
and Rp-cAMPS were not produced by nonspatial learning
factors. First, we examined the recorded swimming speed of
the rats. Intra-EC applications of the drugs failed to alter the
swimming speed of the rats (Figure S5A). Second, we tested the
performance of the rats microinjected with 0.9% NaCl (control,
1 ml/rat, n = 7 rats), baclofen (5 mg/rat in 1 ml, n = 7 rats), and
Rp-cAMPS (18 mg/rat in 1 ml, n = 7 rats) in a visible platform water
maze inwhich no learning is involved (Rudy, 2008). Therewere no
significant differences for the latencies to find the visible platform
among control, baclofen-, and Rp-cAMPS-treated rats (Fig-
ure S5B). Third, we tested whether baclofen and Rp-cAMPS
specifically impact the learning phase. Rats were randomly
Figure 6. Activation of GABABRs Impairs Spatial Learning in Morris
Water Maze
(A) Mean latencies to the platform from the acquisition trials were presented by
groups. Rats were microinjected with normal saline (control), baclofen, Rp-
cAMPS, CGP55845, or CGP55845 followed by baclofen.
(B) Representative swimming traces from the last trial of day 2. Note that ba-
clofen markedly lengthened the swimming path, which was mimicked by Rp-
cAMPS.
(C) Probe trial performance of each group as presented by the proportion of
total time spent in each quadrant of the Morris water maze (**p < 0.01 versus
25% chance in each quadrant).
(D) Horizontal brain sections showing the microinjection sites indicated by the
arrows. Data represent means ± SEM.divided into three groups and received 2 days of the same
acquisition trials in the hidden-platform water maze without
microinjection. On day 3, the three groups of the rats weremicro-
injectedwith normal saline (group 1, n = 7 rats), baclofen (group 2,
n = 7 rats), and Rp-cAMPS (group 3, n = 7 rats), respectively.
A probe trial with the platform unavailable was conducted for
these three groups of rats 15 min after microinjection. Whereas
each group of rats acquired spatial learning rapidly as demon-
strated by significant decreases in latency to find the platform
throughout the trials (Figure S5C1), there were no significant
differences of escape latency among these three groups (Fig-
ure S5C1). In the probe trials, all the three groups of rats showed
a bias for the target quadrant and there were no significant
differences in the time spent in the target quadrant among the
three groups (Figure S5C2), demonstrating that baclofen and
Rp-cAMPS specifically depress the learning phase of the
performance.
We then tested the role of TREK-2 channels in GABABR-medi-
ated inhibition of spatial learning by applying siRNA of TREK-2
channels into the EC through osmotic pumps to knockdown
TREK-2 channel expression. We used several approaches to
confirm the effectiveness of siRNA. First, we immunostained
the EC for TREK-2 channels in rats injected with TREK-2 siRNA
or the scrambled siRNA (Scr-siRNA). Because the immunoreac-
tivity of TREK-2 channels was lower usually in the region of
400–500 mm around the injection site in slices from siRNA-
treated rats (Figure S6), the immunocytochemical quantification
and electrophysiological recordings thereafter were limited to
this range in slices from both siRNA- and Scr-siRNA-treated
rats. We employed two indexes (the number and the mean
optical density of TREK-2-positive cells) to quantify the results.
The number of the TREK-2-positive cells in layer II of the EC
from siRNA-treated rats (4.6 ± 0.4 cells/104 mm2, n = 6 rats)
was markedly reduced compared with that from Scr-siRNA-
treated rats (14.5 ± 0.5 cells/104 mm2, n = 6 rats, p < 0.001,
Figures 7A and 7B). The mean optical density of positive cells
from siRNA-treated rats (0.18 ± 0.01 arbitrary units) was signifi-
cantly lower than that of Scr-siRNA-treated rats (0.41 ± 0.02 arbi-
trary units, p < 0.001, Figure 7B). Second, western blot showed
that the level of TREK-2 proteins in the EC from rats treated with
siRNA was significantly lower than that of rats treated with Scr-
siRNA (Figure 7C). Third, siRNA treatment significantly reduced
baclofen-induced outward HCs (101.9 ± 4.7 pA, n = 16 slices
from 4 Scr-siRNA-treated rats versus 38.2 ± 5.3 pA, n = 13 slices
from 4 siRNA-treated rats, p < 0.001, Figure 7D). Fourth, the
characteristic increases of TREK-2 channels in response to intra-
cellular acidification, heat and AA (in the presence of NMDG and
0 Ca2+) were significantly reduced in rats treated with siRNA
compared with those of the rats treated with the Scr-siRNA
(Figure 7E). Finally, the outward rectification of the voltage-
current relationship of the cells in rats treated with siRNA was
obviously reduced (Figure 7F), suggesting a proportional loss
of TREK-2 channels. However, the RMPs of the stellate neurons
from siRNA-treated rats (55.8 ± 1.2 mV, n = 16) were not
significantly different from those of the Scr-siRNA-treated rats
(56.3 ± 1.5 mV, n = 13, p = 0.86, data not shown). One expla-
nation is that the proportional contribution of TREK-2 channels
to RMPs in siRNA-treated rats could be compensated by otherNeuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc. 237
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by siRNA Annuls Baclofen-Induced Impair-
ment of Spatial Learning
(A) TREK-2 channels were significantly knocked
down after delivery of TREK-2 siRNAs to the EC.
Left two panels: immunoreactivity of TREK-2
channels in a region of the EC adjacent to the injec-
tion site from rats treated with Scr-siRNA or siRNA
in lowmagnification. Right two panels: highmagni-
fication of the regions denoted in the left two
panels.
(B) siRNA treatment significantly deceased the
number of TREK-2-positive cells (left) and the
mean optical density of TREK-2-positive cells
(right) in layer II of the EC.
(C) Western blot showed that siRNA-treatment
significantly decreased the level of TREK-2
channel proteins in the EC (**p < 0.001). A band
that had a molecular mass of 60 kDa corre-
sponding to the reported molecular mass of
TREK-2 channels (Kang et al., 2007b; Simkin
et al., 2008) was detected in the lysates of the EC.
(D) Baclofen-induced increases in outward HCs
were significantly reduced in slices cut from rats
treated with siRNA.
(E) siRNA treatment significantly reduced the
increases in outward HCs induced by intracellular
acidification (262.1 ± 28.4 pA, n = 10 slices from
3 Scr-siRNA treated rats versus 101.8 ± 11.5 pA,
n = 12 slices from 4 siRNA treated rats), heat
(111.1 ± 13.2 pA, n = 10 slices from 3 Scr-siRNA
treated rats versus 37.5 ± 7.4 pA, n = 11 slices
from 3 siRNA treated rats), and AA (in the presence
of NMDG and 0 Ca2+; 59.9 ± 10.6 pA, n = 10 slices
from 3 Scr-siRNA treated rats versus 16.5 ±
3.0 pA, n = 12 slices from 4 siRNA treated rats)
(**p < 0.001).
(F) siRNA treatment conspicuously reduced the
extent of outward rectification of the voltage-
current relationship of the stellate neurons.
Currents at different voltages from each cell were
normalized to the absolute value of the current at
140 mV to minimize the influence of current sizes
on voltage-current relationship. Each trace shows
the averaged voltage-current relationship from
ten cells from three rats treated with siRNA or
Scr-siRNA.
(G) Summarized mean latencies. Note that siRNA knockdown of TREK-2 channels blocked baclofen-induced impairment of spatial learning (**p < 0.01 versus
the corresponding values in control group).
(H) Representative swimming traces from the last trial of day 2 for each group.
(I) Probe trial performance of each group as presented by the proportion of total time spent in each quadrant. The siRNA-treated rats showed a preference for the
target quadrant and intra-EC injection of baclofen into these rats did not prevent the preference of the rats (**p < 0.01 versus 25% chance level). Data represent
means ± SEM.K2P channels as has been observed in TREK-1 (Heurteaux et al.,
2004) and TASK-1 (Aller et al., 2005) knockout mice in which the
RMPs of neurons were not changed.
We then tested the water maze performance of rats treated
with TREK-2 siRNA and Scr-siRNA. Treatment of rats with siRNA
(n = 8 rats) abolished baclofen-induced inhibition of spatial
learning, as demonstrated by decreasing latencies of target
acquisition (siRNA + baclofen group versus baclofen group,
F(1,14) = 111.26, p < 0.001, Figures 7G and 7H). However, Scr-
siRNA treatment (n = 7 rats) failed to alter the effect of baclofen
(Scr-siRNA + baclofen group versus baclofen group, F(1,13) =238 Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc.0.208, p = 0.656, Figures 7G and 7H). siRNA treatment tended
to improve the learning ability of rats when compared with
controls, as shown by the decreased latencies of the last 3 trials
on the first day (Figure 7G, p < 0.01, multivariate ANOVA), which
is consistent with the notion that TREK-2 channels are involved
in learning and memory (Huang and Yu, 2008; Pan et al., 2003).
In the probe trials, preferences for target quadrant were ob-
served only in siRNA-treated rats injected with saline (36.9% ±
2.0%, p < 0.01, Figure 7I) or baclofen (37.9% ± 2.6%, p <
0.01, Figure 7I) whereas Scr-siRNA-treated rats injected with ba-
clofen failed to show bias for the target quadrant (23.6% ± 4.8%,
Neuron
GABAB Activates TREK-2 in Entorhinal Cortexp = 0.75 versus 25% chance level, Figure 7I). Again, siRNA treat-
ment failed to change the swimming speed of rats (Figure S5D).
Together, these results demonstrate that GABABR activation
impairs spatial learning via activation of TREK-2 channels in
the EC.
DISCUSSION
Our results demonstrate that GABABR activation drastically
inhibits neuronal excitability in the EC. GABABR-induced inhibi-
tion is mediated by TREK-2, a type of K2P channels and requires
the functions of Gai proteins and AC-cAMP-PKA pathway. We
further demonstrate that PKA and TREK-2 channels are essential
for GABABR-mediated inhibition of spatial learning assessed by
Morris water maze. As schematically illustrated in Figure 8, our
results support an action mode in which GABABR activation
depresses AC-cAMP-PKA pathway and disinhibits the tonic
inhibition of PKA on TREK-2 channels resulting in depression
of neuronal excitability in the EC and spatial learning.
Ionic Mechanisms Underlying GABABR-Mediated
Inhibition of Neuronal Excitability and Spatial Learning
Resting K+ channels are the major determinants of neuronal
membrane potential and their modulation is one of the principal
mechanisms by which neurotransmitters regulate neuronal
excitability. The following lines of evidence clearly demonstrate
that GABABR activation generates membrane hyperpolarization
by activating a resting K+ conductance. First, replacement of
intracellular K+ with Cs+ failed to induce hyperpolarization but
instead a slight depolarization. Second, the net current gener-
ated by GABABR activation had a reversal potential close to
the K+ reversal potential. Third, elevation of extracellular K+
Figure 8. Schematic Illustration of Signaling Cascade Leading to the
Activation of TREK-2 Channels by GABABRs
Red arrows and minus mark indicate inhibition whereas green arrows and plus
marks denote facilitation. GABABR agonists activate GABABRs resulting in
activation of the inhibitory G proteins (Gi/o). Activation of Gi/o inhibits the
activity of AC leading to a reduction in the production of cAMP from ATP
and an inhibition of PKA activity. Normally, PKA exerts a tonic inhibition on
TREK-2 channels by phosphorylating serine 359 on TREK-2 channels. The
effects of PKA require the function of AKAPs which tether PKA to TREK-2
channels. GABABR-mediated inhibition of PKA annuls PKA-mediated tonic
inhibition of TREK-2 channels resulting in an increase in the function of
TREK-2 channels. The ultimate result is the inhibition of neuronal excitability
in the EC and depression of spatial learning.concentration significantly reduced baclofen-induced hyperpo-
larization. We have also shown that the K+ channels activated
by GABABRs are insensitive to the classic K
+ channel blockers,
but sensitive to Ba2+. Whereas Ba2+ blocks the inward rectifier
K+ channels which are involved in controlling RMPs and
GABABR activation has been shown to activate the inward recti-
fier K+ channels in other neurons (Misgeld et al., 1995), the
inward rectifier K+ channels are unlikely to be the targets for
GABABRs in the EC based on the following two lines of evidence.
First, the inward rectifier K+ channels are sensitive to TEA and
Cs+ whereas application of these classic K+ channel blockers
failed to significantly change baclofen-induced increases in
outward currents. Second, application of tertiapin, a selective
inward rectifier K+ channel inhibitor, did not alter the effects of
baclofen. Together, all our results indicate the involvement of
K2P channels in GABABR-mediated hyperpolarization in the
EC. To identify the involved types of K2P channels, we took the
advantage of the findings that the Ba2+-sensitivity to different
K2P channels has been well-characterized. Among all the K2P
channels, TASK-1 (Han et al., 2002), TASK-3 (Han et al., 2002;
Kim et al., 2000), TREK-1 (Fink et al., 1996), TREK-2 (Han
et al., 2002), TWIK-1 (Lesage et al., 1996), and TRESK (Kang
et al., 2004; Sano et al., 2003) are sensitive to Ba2+. We therefore
examined the roles of these K2P channels in baclofen-induced
hyperpolarization. Our immunocytochemical results showed
that TREK-2 channels are expressed in the EC and intracellular
application of TREK-2 ABs significantly reduced baclofen-
induced increases in outward HCs, indicating that GABABR
activation inhibits neuronal excitability by activating TREK-2
channels. Further evidence to support the requirement of
TREK-2 channels is that application of baclofen to HEK293 cells
coexpressing GABABRs and TREK-2 channels induces hyper-
polarization whereas intracellular application of TREK-2 ABs to
these cells significantly reduced the effects of baclofen.
Signaling Mechanisms whereby GABABR Activation
Inhibits Neuronal Excitability in the EC
K2P channels are modulated by a variety of G protein-coupled
receptors (Chemin et al., 2003; Chen et al., 2006; Deng et al.,
2006; Honore´, 2007; Kim, 2005; Lesage et al., 2000; Mathie
and Veale, 2007; Talley et al., 2000). The a subunits of G proteins
are responsible for the modulation of K2P channels (Chen et al.,
2006; Deng et al., 2006; Lesage et al., 2000). However, Ga
subunits modulate K2P channels in distinct ways; stimulation of
the Gs- or Gq-coupled receptors inhibits (Chemin et al., 2003;
Chen et al., 2006; Deng et al., 2006; Lesage et al., 2000) whereas
activation of Gi-coupled receptors (Lesage et al., 2000) activates
K2P channels. Gq-mediated inhibition of K2P channels is medi-
ated via either intracellular signaling molecules (Chemin et al.,
2003; Kang et al., 2006; Mathie, 2007; Veale et al., 2007) or direct
G protein coupling (Chen et al., 2006; Deng et al., 2006) depend-
ing on the channel type whereas Gi-induced activation requires
intracellular signals because it has been reported that Gi does
not directly interact with K2P channels (Chen et al., 2006). Our
results are consistent with this mechanistic framework because
we have shown that GABABR-mediated increases in outward
HCs were blocked by intracellular application of GDP-b-S or in
slices pretreated with PTX, suggesting the involvement of Gi.Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc. 239
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proteins (Couve et al., 2000). Our results indicate that PKA is
necessary for GABABR-induced increases in outward HCs.
Consistent with our results, both TREK-1 (Fink et al., 1996; Mur-
bartia´n et al., 2005) and TREK-2 (Lesage et al., 2000) channels
contain the phosphorylation site for PKA. Serine 333 in TREK-1
(Murbartia´n et al., 2005) and Serine 359 in TREK-2 (Bang et al.,
2000) are the putative PKA phosphorylation sites and activation
of PKA downregulates the channel activities. We further showed
that mutation of serine 359 to alanine in TREK-2 channels
annulled baclofen-mediated hyperpolarization, suggesting that
the effects of GABABRs are dependent on PKA-mediated phos-
phorylation of TREK-2 channels. These results could also explain
the data that TASK-1 channels for which high immunoreactivity
was detected in the EC (Figures 4A and S1A) are not involved
in GABABR-mediated hyperpolarization because TASK channels
do not contain PKA phosphorylation sites and are not modulated
by PKA (Mathie, 2007).
AKAPs are the proteins that tether PKA to other intracellular
signaling substrates (Beene and Scott, 2007; Hundsrucker and
Klussmann, 2008) and both TREK-1 and TREK-2 channels
interact with AKAP150 (Sandoz et al., 2008; Sandoz et al.,
2006). We therefore tested the roles of AKAPs by application of
the AKAP inhibitory peptide that selectively blocks the conserved
binding domain of different forms of AKAPs to PKA (Beene and
Scott, 2007; Hundsrucker and Klussmann, 2008). Our results
demonstrate that infusion of the AKAP inhibitory peptide via
the recording pipettes remarkably reduced baclofen-induced
hyperpolarization whereas application of the control peptide
was without effect. Together, our results support a scenario in
which GABABR-mediated activation of Gai leads to a downregu-
lation of PKA activity resulting in a reduction in the tonic inhibition
of TREK-2 channels mediated by PKA. The ultimate result is an
upregulation of TREK-2 channel activity leading to hyperpolar-
ization of entorhinal cortical neurons and depression of spatial
learning (Figure 8).
Roles of GABABRs in Spatial Learning
GABABRs have been implicated in spatial learning (Helm et al.,
2005; McNamara and Skelton, 1996). However, the mechanisms
by which GABABRs affect spatial learning have not been deter-
mined. The EC is one of the structures essential for the consoli-
dation and recall of memories (Haist et al., 2001; Squire et al.,
2004; Steffenach et al., 2005). The findings that a high density
of GABABRs is expressed in the EC (Mizukami et al., 2002) and
that activation of GABABRs remarkably depresses neuronal
excitability in the EC suggest that activation of GABABRs
controls learning and memory. Our results using Rp-cAMPS to
mimic the effects of baclofen on spatial learning suggest that
GABABR-induced impairment of spatial learning is mediated by
downregulation of PKA activity. The target of PKA is likely to be
TREK-2 channels because downregulation of TREK-2 channels
by siRNA prevents GABABR-mediated impairment of spatial
learning. Consistent with our results, TREK-2 channels are
involved in the modulation of memory (Huang and Yu, 2008). In
conclusion, our study provides a novel cellular and molecular
mechanism to explain the roles of GABABRs in learning and
memory.240 Neuron 63, 230–243, July 30, 2009 ª2009 Elsevier Inc.EXPERIMENTAL PROCEDURES
Slice Preparation
Entorhinal slices were cut from rat brains as described previously (Deng et al.,
2007). Detailed methods are provided in Supplemental Data.
Whole-Cell Recordings from Stellate Neurons in Layer II of the EC
Whole-cell patch-clamp recordings using an Axopatch 200B or two Multi-
clamp 700B amplifiers (Molecular Devices, Sunnyvale, CA) in current- or
voltage-clampmode weremade from stellate neurons in layer II of the EC visu-
ally identified with infrared video microscopy (Olympus BX51WI) and differen-
tial interference contrast optics as described previously (Deng et al., 2007).
Unless stated otherwise, all the recordings were conducted at room tempera-
ture (23C). The recording electrodes were filled with (in mM) 130 K+-gluco-
nate, 0.5 EGTA, 2 MgCl2, 5 NaCl, 2 ATP2Na, 0.4 GTPNa, and 10 HEPES
(pH 7.4). The extracellular solution comprised (in mM) 130 NaCl, 24 NaHCO3,
3.5 KCl, 1.25 NaH2PO4, 2.5 CaCl2, 1.5 MgCl2, and 10 glucose, saturated with
95% O2 and 5% CO2 (pH 7.4). Data were filtered at 2 kHz, digitized at 10 kHz,
acquired on-line and analyzed after-line using pCLAMP 9 software (Molecular
Devices).
AP firing was induced by injecting a positive current to bring the RMP to
50 mV. Baclofen was applied after the AP firing had been stable for 5–
10 min. Frequency of APs was calculated by Mini Analysis 6.0.1 (Synaptosoft
Inc., Decatur, GA). HCs at 60 mV were recorded in the extracellular solution
containing TTX (0.5 mM) and then averaged per minute. We subtracted the
average of the HCs recorded for the last minute prior to the application of
baclofen from those recorded at different time points to zero the basal level
of HCs for better comparison unless stated otherwise. Voltage-current curves
were constructed by using a ramp protocol from 140 mV to 0 mV at a speed
of 0.1 mV/ms in the external solution supplemented with (in mM) 0.5 TTX, 100
CdCl2, 10 DNQX, 100 dl-APV, and 10 bicuculline. We compared the voltage-
current curves recorded before and during the application of baclofen for
5 min.
Transfection and Electrophysiological Recordings
from Transfected Cells
Detailed procedures for transfection of HEK293 cells and electrophysiological
recordings from the transfected cells were described previously (Deng et al.,
2007). HEK293 cells were transfected with GABABRs alone, or together with
TREK-2 channels or with TASK-1, TASK-3, TWIK-1, TREK-1, or TREK-2 chan-
nels alone as specified. Green fluorescent protein (GFP) was cotransfected for
each experiment to identify the transfected cells. Details of the cDNA
constructs are provided in Supplemental Data.
Immunocytochemistry
The methods for immunocytochemistry were described previously (Deng and
Lei, 2008). Briefly, horizontal sections (20 mm) from rat brain were washed in
0.1 M PBS and then treated with 0.3% hydrogen peroxide (H2O2) for 10 min
to quench endogenous peroxidase activity. After being rinsed in 0.1 M PBS
containing 1% Triton X-100 and 5% normal donkey serum for 30 min, sections
were incubated with the primary goat ABs to TASK-1, TASK-3, TWIK-1,
TREK-1, or TREK-2 (Santa Cruz Biotechnology Inc.) at a dilution of 1:200 at
4C for 12 hr. Sections were incubated at room temperature initially with bio-
tinylated donkey anti-goat IgG (Immunocruz Staining System, Santa Cruz
Biotechnology Inc.) for 1 hr, and then with HRP-streptavidin complex (Immu-
nocruz Staining System) for 1 hr. After each incubation, sections were washed
three times for a total of 30 min. Diaminobenzidine (Immunocruz Staining
System) was used for a color reaction to detect the positive signals. We strictly
controlled the incubation time to obtain comparable results. Finally, sections
were mounted on slides, dehydrated through an alcohol range, cleared in
xylene and covered with coverslips. We stained 15 nonadjacent sections
for each rat and each staining was repeated by using six rats. For the siRNA
experiments, we stained sections from two Scr-siRNA-treated (control) rats
and two siRNA-treated rats each time and repeated three times. The images
were analyzed with Image-Pro Plus 6.0 (Media Cybernetics, Inc., Bethesda,
MD). Briefly, we set the range of optical densities and area (size of cells) to
define the countable positive cells. Only neurons with optical densities five
Neuron
GABAB Activates TREK-2 in Entorhinal Cortextimesmore than backgroundwere considered positive. For the cell size, we set
the range (area) from 70 to 130 mm2 according to the size of stellate cells in our
setting. Under this condition, the software counted the cell number automati-
cally. Each detected cell was then inspected visually to exclude obvious
artifacts.
Water Maze Task
All surgical procedures were performed under aseptic conditions. After being
anesthetized with pentobarbital sodium (40mg/kg), male Sprague-Dawley rats
(150–200 g) were placed on a stereotaxic frame and implanted bilaterally with
stainless steel guide cannulae (23 gauge, Plastics One, Roanoke, VA) in the en-
torhinal cortices. The cannulae were cemented into place with dental acrylic.
The coordinates for the implantation were based on the brain atlas of Paxinos
and Watson (Paxinos and Watson, 1986) and our preliminary experiments;
anteroposterior (AP) 6.5 mm, mediolateral (ML) ± 4.5 mm and dorsoventral
(DV) 5.6 mm. Cannulation sites were confirmed at the end of each experi-
ment by slicing rat brain, Nissl staining with cresyl violet (0.1%) and viewing
under a microscope (Figure 6D). Data from the rats with incorrect injection
sites were excluded from analysis. We also infused siRNA to knock down
TREK-2 channels in the EC by using osmotic pumps. Detailed procedures
for this experiment are provided in Supplemental Data.
Morris water maze test was conducted after 1 week of postsurgical re-
covery. For the hidden-platform test, rats were trained to locate a hidden
platform (10 cm in diameter, submerged 1 cm) in a water maze (1.2 m in diam-
eter) as described previously (Xu et al., 2004). The water maze was filled with
opaque water at a temperature of 20C ± 0.5C. Video tracking was performed
using a computerized water maze system (2020 Plus Tracking System), allow-
ing measurement of a number of parameters, including latency to find the
platform, swimming distance, swimming speed, thigmotaxic behavior and
quadrant analyses. Rats received 2 days of acquisition trials, each day
comprising six consecutive trials, during which the platform was in a fixed
position of a quadrant. On each trial, the rat was gently put in the water
maze facing the wall with semirandomized starting positions, released and al-
lowed to search for the platform for 90 s. If the rat failed to find the platform
within this time, it was guided to the platform by the experimenter. The rat
was allowed to stay on the platform for 30 s before next trial. The intertrial
time was approximately 45 s. After completion of all six trials, the rats were
dried off with towels. A probe trial with the platform unavailable for 90 s was
conducted on day 3. The rats were released from the pool side opposite to
the target (platform) quadrant. Time spent in the target quadrant was
compared with time spent in other quadrants. The chance level spent in
each quadrant is 25%. Rats received drug infusion 15 min prior to the acqui-
sition trials on days 1 and 2 but no drug treatment on day 3 (probe trial) unless
stated otherwise. All animals received 1 ml of one or two specific drugs via the
27 gauge internal cannulae that protruded approximately 0.5 mm from the
guide cannulae. Infusions (0.5 ml/min) were made with a microinfusion pump
(WPI, SP230IW).
For the visible-platform test, the escape platform was protruded to 1.5 cm
above water surface and the edge of the platform above water surface was
covered with a black water-proof tape. The visible platform was placed in
distinct positions for each trial of the six trials of each day for 2 days. The
animal was placed into the tank facing the wall at a start point opposite to
the platform from trial to trail. The same amount of saline, baclofen and
Rp-cAMPS was microinjected each day before the visible-platform test.
Western Blot
Tissues for western blot were taken from three Scr-siRNA- and three siRNA-
treated rats. For details, please see Supplemental Data.
Data Analysis
Data are presented as the means ± SEM. Baclofen concentration-response
curve was fit by the Hill equation: I = Imax 3 {1/[1 + (EC50/[ligand])
n]}, where
Imax is the maximum response, EC50 is the concentration of ligand producing
a half-maximal response, and n is the Hill coefficient. Paired or unpaired
t test was used to compare electrophysiological, quantified immunohisto-
chemical and western blot data as appropriate. For the data obtained from
thewater maze experiments, we used the repeated-measures andmultivariateANOVA process of the general linear model in SPSS 11.0 statistical software
and gave comparison among different groups and different measuring time
points pairwise. P values are reported throughout the text and significance
was set as p < 0.05. N number in the text represents the cells examined, unless
stated otherwise.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures and six
figures and can be found with this article online at http://www.cell.com/
neuron/supplemental/S0896-6273(09)00509-1.
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